PubRank

Andrea R Florl

Author PubWeight™ 17.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res 2002 2.34
2 Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 2002 1.28
3 Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int J Cancer 2003 1.10
4 Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer. Cancer Biol Ther 2007 1.05
5 DNA methylation alterations in urothelial carcinoma. Cancer Biol Ther 2006 0.99
6 Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Mol Cancer 2007 0.98
7 Multiple mechanisms downregulate CDKN1C in human bladder cancer. Int J Cancer 2005 0.98
8 Application of a modified real-time PCR technique for relative gene copy number quantification to the determination of the relationship between NKX3.1 loss and MYC gain in prostate cancer. Clin Chem 2005 0.93
9 Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes Chromosomes Cancer 2005 0.91
10 Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer. Int J Cancer 2008 0.91
11 Distinctive differences in DNA double-strand break repair between normal urothelial and urothelial carcinoma cells. Mutat Res 2007 0.91
12 In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer. Exp Mol Pathol 2006 0.88
13 Correlation of hMLH1 and HPP1 hypermethylation in gastric, but not in esophageal and cardiac adenocarcinoma. Int J Cancer 2004 0.83
14 Hypomethylation of the XIST gene promoter in prostate cancer. Oncol Res 2005 0.82
15 DNA methylation in placentas of interspecies mouse hybrids. Genetics 2003 0.81
16 Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines. Cell Oncol (Dordr) 2012 0.81
17 Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage. Eur Urol 2005 0.81
18 Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation. Eur J Cancer 2006 0.79
19 Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer. Hum Mutat 2004 0.75